Page last updated: 2024-11-02

pamidronate and Carcinoma, Pancreatic Ductal

pamidronate has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez-Villasana, V1
Rodriguez-Aguayo, C1
Arumugam, T1
Cruz-Monserrate, Z1
Fuentes-Mattei, E1
Deng, D1
Hwang, RF1
Wang, H1
Ivan, C1
Garza, RJ1
Cohen, E1
Gao, H1
Armaiz-Pena, GN1
Del C Monroig-Bosque, P1
Philip, B1
Rashed, MH1
Aslan, B1
Erdogan, MA1
Gutierrez-Puente, Y1
Ozpolat, B1
Reuben, JM1
Sood, AK1
Logsdon, C1
Lopez-Berestein, G1

Other Studies

1 other study available for pamidronate and Carcinoma, Pancreatic Ductal

ArticleYear
Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.
    Molecular cancer therapeutics, 2014, Volume: 13, Issue:11

    Topics: Adult; Albumins; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferat

2014